Eun Hee Kim Selected Research

(166)holmium-chitosan complex

12/2005

A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Hee Kim Research Topics

Disease

24	Neoplasms (Cancer) 01/2020 - 12/2005
12	Inflammation (Inflammations) 03/2022 - 03/2010
11	Glioma (Gliomas) 08/2013 - 01/2004
10	Stomach Neoplasms (Stomach Cancer) 01/2020 - 09/2012
8	Stroke (Strokes) 01/2022 - 06/2003
7	Obesity 12/2021 - 01/2011
6	Allergic Rhinitis 03/2022 - 01/2016
6	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 08/2004
6	Hypertension (High Blood Pressure) 12/2016 - 01/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 09/2016 - 04/2010
5	Atherosclerosis 01/2018 - 05/2008
5	Coronary Artery Disease (Coronary Atherosclerosis) 11/2015 - 04/2010
4	Insulin Resistance 12/2021 - 05/2014
3	Rhinitis 03/2022 - 03/2017
3	Sneezing 11/2020 - 01/2020
3	Ischemic Stroke 01/2019 - 10/2005
3	Infarction (Infarctions) 01/2019 - 05/2007
3	Neoplasm Metastasis (Metastasis) 02/2017 - 08/2014
3	Lung Neoplasms (Lung Cancer) 10/2016 - 11/2015
3	Breast Neoplasms (Breast Cancer) 09/2015 - 03/2010
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2015 - 05/2013
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2014 - 10/2012
3	Infections 11/2013 - 03/2010
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2013 - 05/2007
3	Crohn Disease (Crohn's Disease) 04/2013 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 10/2021 - 06/2010
2	Nasal Polyps (Nasal Polyp) 05/2020 - 05/2014
2	Cicatrix (Scar) 03/2020 - 01/2014
2	Adenocarcinoma 07/2017 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017 - 08/2016
2	Wounds and Injuries (Trauma) 02/2017 - 07/2003
2	Carcinoma (Carcinomatosis) 09/2015 - 01/2014
2	Pain (Aches) 06/2015 - 09/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 02/2013
2	Hypercholesterolemia 01/2015 - 01/2011
2	Disease Progression 09/2014 - 01/2014
2	Colitis 05/2014 - 10/2012
2	Polyps 05/2014 - 04/2013
2	Ulcerative Colitis 04/2013 - 10/2012
2	Hypotension (Low Blood Pressure) 04/2013 - 12/2006
2	Weight Loss (Weight Reduction) 01/2011 - 03/2010
2	Body Weight (Weight, Body) 01/2011 - 03/2010
1	Pneumoperitoneum 01/2022
1	Non-alcoholic Fatty Liver Disease 12/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2008
12	FlavonoidsIBA 01/2020 - 09/2007
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013 - 01/2004
10	LigandsIBA 08/2013 - 01/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2012
8	CaspasesIBA 01/2018 - 01/2004
7	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 02/2013
7	Caspase 3 (Caspase-3)IBA 08/2016 - 01/2004
7	SurvivinIBA 01/2011 - 01/2004
6	CytokinesIBA 03/2022 - 01/2015
5	Triglycerides (Triacylglycerol)IBA 12/2021 - 01/2015
5	AntioxidantsIBA 08/2016 - 12/2012
5	Death Domain ReceptorsIBA 01/2011 - 02/2006
4	Therapeutic UsesIBA 03/2022 - 09/2007
4	ORALIT (ORS)IBA 12/2018 - 05/2013
4	EnzymesIBA 08/2013 - 06/2003
3	Immunoglobulin E (IgE)IBA 01/2020 - 01/2015
3	InterleukinsIBA 01/2018 - 03/2017
3	Matrix Metalloproteinases (MMPs)IBA 02/2017 - 06/2003
3	ImmunosorbentsIBA 08/2013 - 06/2003
3	Superoxides (Superoxide)IBA 03/2010 - 07/2007
2	Anti-Allergic Agents (Antiallergic Agents)IBA 03/2022 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 03/2022 - 11/2020
2	CalciumIBA 12/2020 - 12/2014
2	Indicators and Reagents (Reagents)IBA 08/2020 - 05/2013
2	Interleukin-17 (Interleukin 17)IBA 05/2020 - 03/2017
2	CollagenIBA 03/2020 - 05/2014
2	scutellareinIBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2019
2	pectolinarigeninIBA 10/2018 - 08/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 05/2014
2	Pharmaceutical PreparationsIBA 03/2017 - 01/2014
2	LipopolysaccharidesIBA 03/2017 - 03/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2017 - 08/2014
2	LDL CholesterolIBA 09/2016 - 01/2015
2	Insulin (Novolin)FDA Link 07/2016 - 05/2014
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2015
2	Biological ProductsIBA 09/2015 - 10/2012
2	Messenger RNA (mRNA)IBA 07/2015 - 11/2013
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2013 - 12/2008
2	CurcuminIBA 11/2012 - 03/2010
2	Transcription Factors (Transcription Factor)IBA 03/2011 - 03/2010
2	Cystatin CIBA 06/2010 - 04/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008 - 02/2006
2	salicylhydroxamic acid (SHAM)IBA 02/2008 - 05/2007
2	Selenious Acid (Selenite)IBA 01/2008 - 07/2007
2	DiquatIBA 01/2008 - 07/2007
2	TNF-Related Apoptosis-Inducing LigandIBA 02/2006 - 10/2005
1	Conditioned Culture MediaIBA 03/2022

Therapy/Procedure

16	Therapeutics 01/2022 - 12/2005
2	Lasers (Laser) 01/2020 - 01/2014
2	Traditional Medicine (Folk Remedies) 10/2016 - 01/2012
2	Stents 01/2013 - 07/2003
1	Low-Level Light Therapy (LLLT) 03/2022
1	Intravenous Injections 01/2022
1	Laparotomy 01/2022